Work

Efficacy and safety of adjunctive bitopertin (5 and 10mg) versus placebo in subjects with persistent predominant negative symptoms of schizophrenia treated with antipsychotics — Results from the phase III DayLyte study

Year: 2014

Type: article

Source: Schizophrenia Research

DOI: 10.1016/j.schres.2014.07.038

Authors: Celso Arango, Henry Nasrallah, Stephen Lawrie, Tania Ochi Lohmann, Jon Luca Zhu, George Garibaldi, Alice Wang, Dragana Bugarski-Kirola

Institutions: Hospital General Universitario Gregorio Marañón, Saint Louis University, University of Edinburgh, F. Hoffmann-La Roche AG, Roche (China)

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1976288656

FWCI: 2.036

Cites:

Cited by: 11

Related to: 10